"Glutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.
| Descriptor ID |
D005973
|
| MeSH Number(s) |
D12.125.068.330 D12.125.095.461 D12.125.154.424
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glutamine".
Below are MeSH descriptors whose meaning is more specific than "Glutamine".
This graph shows the total number of publications written about "Glutamine" by people in this website by year, and whether "Glutamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 3 | 1 | 4 |
| 2018 | 2 | 5 | 7 |
| 2019 | 3 | 3 | 6 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glutamine" by people in Profiles.
-
Improved Synthesis of a Cyclic Glutamine Analogue Used in Antiviral Agents Targeting 3C and 3CL Proteases Including SARS-CoV-2 Mpro. J Org Chem. 2021 09 17; 86(18):13104-13110.
-
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro). J Med Chem. 2022 02 24; 65(4):2880-2904.
-
Immunonutrition effects on coping with COVID-19. Food Funct. 2021 Sep 07; 12(17):7637-7650.
-
SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat Commun. 2021 03 25; 12(1):1876.
-
Vitamin D, zinc and glutamine: Synergistic action with OncoTherad immunomodulator in interferon signaling and COVID-19 (Review). Int J Mol Med. 2021 03; 47(3).
-
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nat Chem Biol. 2021 02; 17(2):222-228.
-
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19). J Transl Med. 2020 06 25; 18(1):257.
-
Endophytic Bacteria as Contributors to Theanine Production in Camellia sinensis. J Agric Food Chem. 2019 Sep 25; 67(38):10685-10693.
-
Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593.
-
Glutamine Therapy Reduces Inflammation and Extracellular Trap Release in Experimental Acute Respiratory Distress Syndrome of Pulmonary Origin. Nutrients. 2019 Apr 12; 11(4).